Proteus is a genus of gram negative Proteobacteria. Species include Proteus mirabilis which is a cause of Urinary Tract infections in humans, often resulting in the production of urinary stones.
Species of Proteus are being sequenced as part of the Public Health England NCTC reference collection. Please see the Wellcome Trust Sanger Institute's NCTC page for more details.
The Sanger Institute has sequenced the genome of Proteus mirabilis strain HI4320 in collaboration with Prof. Harry Mobley at the Department of Microbiology and Immunology, University of Michigan Medical School, U.S.A.
Published Genome Data
The chromosome is 4.063 Mb with a G+C content of 38.88%, and there is a single plasmid of 36.289 kb.
Both the chromosome and the plasmid are available from the EMBL/GenBank databases with accession numbers AM942759 and AM942760 respectively.
Shotgun and assembly data from this project are available from our FTP site.
- HPACC Murray project
- Whole genome sequencing of 1200 bacterial strains isolated from healthy faecal transplant donors and recurrent C. difficile patients
- NCTC 3000
- Pacbio sequencing of KPC Proteus mirabilis
- Genomic characterization of bladder bacteria from healthy and infected women
- Bloodstream surveillence across Africas
- Commensal bacterial genomes from health and disease
HPACC Murray project
Pacbio sequencing of KPC Proteus mirabilis
|3414STDY6104932||Proteus mirabilis AOUC004||ERR987690|
Genomic characterization of bladder bacteria from healthy and infected women
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
Journal of bacteriology 2008;190;11;4027-37
PUBMED: 18375554; PMC: 2395036; DOI: 10.1128/JB.01981-07
Data Use Statement
This sequencing centre plans on publishing the completed and annotated sequences in a peer-reviewed journal as soon as possible. Permission of the principal investigator should be obtained before publishing analyses of the sequence/open reading frames/genes on a chromosome or genome scale. See our data sharing policy.
Please address all sequencing enquiries to: email@example.com